Kaken Pharmaceutical Co., Ltd. (TYO:4521)
Japan
· Delayed Price · Currency is JPY 4,285.00
+20.00 (0.47%)
At close: Mar 6, 2026
Kaken Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 162,266 | 176,794 | 130,992 | 138,463 | 147,114 | 166,112 | Upgrade
|
| Market Cap Growth | 0.79% | 34.97% | -5.40% | -5.88% | -11.44% | -15.14% | Upgrade
|
| Enterprise Value | 120,278 | 100,891 | 68,690 | 72,334 | 84,580 | 101,291 | Upgrade
|
| Last Close Price | 4285.00 | 4370.72 | 3223.47 | 3301.76 | 3340.15 | 3595.09 | Upgrade
|
| PE Ratio | - | 12.68 | 16.32 | 25.45 | 15.41 | 12.39 | Upgrade
|
| Forward PE | 69.30 | 22.01 | 19.39 | 13.57 | 13.10 | 13.02 | Upgrade
|
| PS Ratio | 2.14 | 1.88 | 1.82 | 1.90 | 1.94 | 2.22 | Upgrade
|
| PB Ratio | 1.11 | 1.16 | 0.91 | 1.01 | 1.06 | 1.22 | Upgrade
|
| P/TBV Ratio | 1.28 | 1.33 | 0.96 | 1.07 | 1.14 | 1.23 | Upgrade
|
| P/FCF Ratio | - | 6.90 | 182.95 | 19.06 | 14.21 | 13.39 | Upgrade
|
| P/OCF Ratio | - | 5.94 | 50.83 | 14.96 | 11.03 | 11.55 | Upgrade
|
| EV/Sales Ratio | 1.59 | 1.07 | 0.95 | 0.99 | 1.11 | 1.35 | Upgrade
|
| EV/EBITDA Ratio | - | 4.28 | 5.60 | 6.85 | 4.33 | 5.04 | Upgrade
|
| EV/EBIT Ratio | - | 4.80 | 7.22 | 9.04 | 4.96 | 5.69 | Upgrade
|
| EV/FCF Ratio | - | 3.94 | 95.94 | 9.96 | 8.17 | 8.16 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.16 | 0.31 | 0.36 | 0.20 | 0.19 | Upgrade
|
| Debt / FCF Ratio | - | 0.15 | 5.38 | 0.53 | 0.37 | 0.31 | Upgrade
|
| Net Debt / Equity Ratio | -0.29 | -0.43 | -0.43 | -0.51 | -0.51 | -0.54 | Upgrade
|
| Net Debt / EBITDA Ratio | 29.44 | -2.81 | -5.01 | -6.66 | -3.62 | -3.65 | Upgrade
|
| Net Debt / FCF Ratio | - | -2.58 | -85.86 | -9.69 | -6.84 | -5.92 | Upgrade
|
| Asset Turnover | - | 0.52 | 0.43 | 0.44 | 0.46 | 0.47 | Upgrade
|
| Inventory Turnover | - | 1.96 | 2.05 | 2.19 | 2.28 | 2.48 | Upgrade
|
| Quick Ratio | 3.11 | 3.01 | 4.68 | 4.49 | 4.98 | 4.60 | Upgrade
|
| Current Ratio | 4.09 | 3.67 | 5.62 | 5.27 | 5.81 | 5.34 | Upgrade
|
| Return on Equity (ROE) | - | 9.41% | 5.72% | 3.95% | 6.96% | 10.13% | Upgrade
|
| Return on Assets (ROA) | - | 7.26% | 3.52% | 3.02% | 6.49% | 6.92% | Upgrade
|
| Return on Invested Capital (ROIC) | -3.86% | 17.90% | 10.48% | 9.53% | 18.01% | 20.99% | Upgrade
|
| Return on Capital Employed (ROCE) | -2.50% | 13.10% | 6.20% | 5.50% | 11.70% | 12.50% | Upgrade
|
| Earnings Yield | -2.36% | 7.89% | 6.13% | 3.93% | 6.49% | 8.07% | Upgrade
|
| FCF Yield | - | 14.50% | 0.55% | 5.25% | 7.03% | 7.47% | Upgrade
|
| Dividend Yield | 4.43% | 3.43% | 4.65% | 4.54% | 4.49% | 4.17% | Upgrade
|
| Payout Ratio | - | 51.62% | 70.49% | 103.84% | 59.84% | 43.35% | Upgrade
|
| Buyback Yield / Dilution | 0.01% | -1.13% | -0.44% | 1.07% | 1.59% | 1.41% | Upgrade
|
| Total Shareholder Return | 4.44% | 2.31% | 4.21% | 5.62% | 6.08% | 5.58% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.